Do angiotensin II type 1 receptor blockers have molecular effects?
Miura
Shin-Ichiro
S
Department of Cardiology, Fukuoka University School of Medicine, Fukuoka, Japan. miuras@cis.fukuoka-u.ac.jp
Saku
Keijiro
K
D000804:Angiotensin II / Q000097:blood; D047228:Angiotensin II Type 1 Receptor Blockers / Q000494:pharmacology*; D000085962:Angiotensin-Converting Enzyme 2; D048049:Extracellular Signal-Regulated MAP Kinases / Q000378:metabolism; D006801:Humans; D007703:Peptidyl-Dipeptidase A / Q000235:genetics
D047228:Angiotensin II Type 1 Receptor Blockers; D000804:Angiotensin II; D048049:Extracellular Signal-Regulated MAP Kinases; D007703:Peptidyl-Dipeptidase A; C000705307:ACE2 protein, human; D000085962:Angiotensin-Converting Enzyme 2